Novo Nordisk A/S shares rise 1.71% premarket after Data I/O Corporation's Q2 2025 earnings call.

Friday, Jul 25, 2025 4:03 am ET1min read
Novo Nordisk A/S rose 1.71% in premarket trading. The company's stock price increase may be attributed to the positive news of West Pharma raising its annual profit forecast due to strong demand for its drug components.

Novo Nordisk A/S shares rise 1.71% premarket after Data I/O Corporation's Q2 2025 earnings call.

Comments



Add a public comment...
No comments

No comments yet